OIS Weekly: Company/Market Watch – Ocuphire Pharma Reports Positive Top-line Results in the MIRA-2 Phase III Registration Trial Mar 24, 2021
Ocuphire Represented by Mina Sooch Participated in Crain’s Detroit's Event: “M&A Lessons from the Biggest Deals of 2020" Mar 10, 2021
Mediaplanet’s 2020 Vision Health Edition Features Night Vision Disturbances and Ocuphire Pharma’s Leadership in Investigating Potential Treatments for the Condition Sep 30, 2020
